1964
DOI: 10.1016/0039-128x(64)90018-2
|View full text |Cite
|
Sign up to set email alerts
|

Steroid and lipid metabolism.1 The hypocholesteremic effect of estrogen metabolites

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
16
0

Year Published

1966
1966
2006
2006

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 51 publications
(16 citation statements)
references
References 9 publications
0
16
0
Order By: Relevance
“…These mechanisms include the activities of the enzymes participating in the biosynthesis or catabolism of estradiol, such as CYP19 (aromatase; an enzyme converting testosterone to estrogens), or CYP1A (group of enzymes involved in estradiol catabolism) [44]. Some reports have shown that the CYP1A-dependent EROD activity induced by AhR agonists can stimulate the metabolism of E 2 to a weak estrogen, 2-hydroxyestrone (2-OHE1) [33,[45][46][47][48][49][50], and inhibit the aromatase activity [32]. In addition, it has been suggested that the antiestrogenic activity of AhR agonists may be complex and related to cross-talk between the AhR and ER signaling pathways [51][52][53][54].…”
Section: Discussionmentioning
confidence: 99%
“…These mechanisms include the activities of the enzymes participating in the biosynthesis or catabolism of estradiol, such as CYP19 (aromatase; an enzyme converting testosterone to estrogens), or CYP1A (group of enzymes involved in estradiol catabolism) [44]. Some reports have shown that the CYP1A-dependent EROD activity induced by AhR agonists can stimulate the metabolism of E 2 to a weak estrogen, 2-hydroxyestrone (2-OHE1) [33,[45][46][47][48][49][50], and inhibit the aromatase activity [32]. In addition, it has been suggested that the antiestrogenic activity of AhR agonists may be complex and related to cross-talk between the AhR and ER signaling pathways [51][52][53][54].…”
Section: Discussionmentioning
confidence: 99%
“…Decreased peripheral conversion of androstenedione to estrone may be implicated as this conversion is thought to occur to some extent in fat cells (126,127). One important observation, in fact, shows that with weight loss the metabolism of estradiol which normally proceeds with 16 hydroxylation, is decreased in favor of 2 hydroxylation and the eventual formation of the catechol estrogen 2-methoxy estrone which has no intrinsic activity (128,129) and may in fact act as an anti-estrogen as it will bind to some estrogen receptors (130). This compound also possesses the structure of a catechol estrogen in that it has the potential for interacting both with catecholamine and estrogen mediated systems in the central nervous system.…”
Section: Structural and Metabolic Mechanismsmentioning
confidence: 97%
“…Several synthetic agents have been shown to inhibit cholesterol biosynthesis and cause accumulation of desmosterol ( 1,2,3). The latter phenomenon has been correlated with inhibitory effect of the compound on reduction of desmosterol to cholesterol (4) and lanosterol to dihydrolanosterol (5).…”
mentioning
confidence: 97%